Westudied three siblings with Bartter's syndrome associated with hypomagnesemia;two of them showing marked hypomagnesemiaand the other mild hypomagnesemia.Urinary potassium, sodium and chloride excretions were determined and distal fractional chloride reabsorption and free water clearance on water loading test were comparedbefore and after magnesiumsupplementation. Baseline urinary potassium and magnesiumexcretions were elevated in spite of the decreased plasma levels, whereas distal fractional chloride reabsorption and free water clearance were depressed in all patients. Magnesiumrepletion resulted in significant decrease in urinary potassium, sodium and chloride and subsequent increase in plasma potassium in all patients. However,neither distal fractional chloride reabsorption nor free water clearance was affected. Hypomagnesemiamay contribute to urinary potassium wasting and aggravate urinary sodium and chloride wasting in familial Bartter's syndrome by a mechanism independent of the defect in free-water formation by the active reabsorption of chloride in Henle's loop. (Internal Medicine 33: 1-5, 1994) 
Introduction
Bartter's syndrome, first reported in 1962, is characterized by hypokalemia, metabolic alkalosis, hyperreninemia, secondary aldosteronism, hyperplasia of juxtaglomerular cells and normal blood pressure (1) . A defect in chloride and sodium reabsorption in the thick ascending limb of Henle's loop provides a reasonable explanation for the serial events that characterize this syndrome (2, 3) . Although hypomagnesemia has also been noted in some of the patients with this syndrome, little is known about its pathophysiological significance (4) . Experimental magnesiumdepletion, on the other hand, causes hypopotassemia which is due to an increased renal loss of potassium (5) . Potassium depletion then might also affect chloride reabsorption in the loop of Henle (6, 7) . Abnormal renal handling of magnesium could occur in the syndrome, in as much as the divalent cation is reabsorbed in the thick ascending limb of Henle's loop (8) (9) (10) . Thus hypomagnesemia in the syndromemayreflect a complex tubular disorder which also includes a defect of chloride reabsorption. Howeverthe role of hypomagnesemiain the syndrome has not yet been clearly elucidated ( 1 1). Moreover, the effects of magnesium repletion on hypokalemia, hyperreninemia and hyperaldosteronism have not been systematically studied in familial Bartter' s syndrome associated with hypomagnesemia. The present study was undertaken to determine the effect of magnesiumrepletion on free water clearance, distal fractional chloride reabsorption, renin-angiotensin-aldosterone system and urinary sodium, potassium and chloride excretions in three siblings with familial Bartter' s syndrome and hypomagnesemia.
Case Reports
Case1
A 24-year-old Japanese womanwas admitted to our hospital because oftetany of greater than a ten-year duration. A percutaneous kidney biopsy specimen revealed hypertrophic and hyperplastic juxtaglomerular apparatus (Fig. 1 ).
Case2
The younger sister of Case 1 aged 20 was referred to our hospital for evaluation of tetany. She had complained of carpopedal spasmus similar to her elder sister since the age of The 17-year-old younger brother of Cases 1 and 2 was admitted for the evaluation of hypokalemia. He had not expe- rienced tetany, muscle weakness, spasmus, or other symptoms. He was 172 cm tall and weighed 60 kg. Blood pressure was 1 10/70 mmHgwithout orthostatic change. Physical examination did not reveal any abnormalities. Laboratory data on admission revealed the following : serum sodium 139 mEq/1, potassium 2.6 mEq/1, chloride 97 mEq/1, bicarbonate 29.6 mEq/1, magnesium 1.6 mg/dl, calcium 9.3 mg/ dl, phosphate 4.3 mg/dl, uric acid 6.7 mg/dl, blood urea nitrogen 20.9 mg/dl and creatinine 1.0 mg/dl. During the observation period, he showed mild hypomagnesemia ranging from 1.5 to 1.8 mg/dl. Endogenous creatinine clearance was 99 ml/min/ Other family members including their parents and grandmothers were healthy and showeda normal serum potassium and magnesium level.
Methods
The three siblings were admitted to the metabolic ward during the studies. The following protocol had been approved by the ethical committee of Tokyo Medical and Dental University. They were placed on a diet containing 120 mEqsodium, 80 mEqpotassium, and 250 mg magnesium daily throughout the study. Three days after admission, the study was initiated. After a baseline observation period of seven days, magnesiumsulphate, containing 400 mg of magnesium, was infused daily for seven days. The duration of Mginfusion was five hours at a speed of 80/h. Urine was collected for 24-hour periods except during half-saline infusion tests. The endogenous creatinine clearance was used to estimate the glomerular filtration rate (12) . The mean±standard error of urinary and serum electrolytes for seven days before and during magnesium infusion periods was considered as the average value of urinary and serum electrolytes. Free water clearance (CH2q) studies, to estimate the index of chloride reabsorption in the ascending limb of the loop ofHenle (13, 14) , were performed on the morning after seven-day baseline and Mg infusion periods.
To suppress endogenous vasopressin, each patient was first given a bolus of 0.45%saline solution intravenously over a 40 minutes (20 ml/kg body weight), then the infusion rate was 5 ml/min, and was subsequently adjusted to exceed urinary flow by 5 ml/min. Blood and urine samples were obtained every 30 minutes after completing an initial load of intravenous half saline to measure creatinine, osmolality, sodium, potassium, chloride and magnesiumconcentrations. To confirm endogenous vasopressin suppression, plasma arginine vasopressin concentrations were determined both at the end of initial half-saline load and at the end of each infusion. Free water clearance was calculated by the formula: CH 0 = V-(UosmV/Sosm), where V = urine flow, Uosm= urine osmolality and Sosm = serum osmolality. Chloride clearance (CC1) was calculated by the formula: CC1 = UC1V/SC1, where UC1 = urinary chloride concentration and SC1 = serum chloride concentration. Distal fractional chloride reabsorption was calculated as CH2O/(CH2o+Ccl).
Values are expressed as meardzstandard error unless otherwise stated. Significance of data was determined by Student's ttest.
Results
(1) Baseline data before magnesium infusion
The three patients strictly followed our dietary regimen during the study period. Average 24-hour urinary excretions of potassium, sodium, chloride and magnesium for seven days were 65.0+5.1 mEq, 134±8 mEq, 135+8 mEq and 1 15±22 mg, respectively (mean of three cases). Potassium and magnesium excretions were markedly elevated in spite of decreased serum levels at 2.3±0. (2) Changes during magnesium infusion After magnesium sulphate infusion (400 mg/day), the average urinary potassium excretion decreased significantly from 68±3 to 28±3 mEq/day in Case 1 (p<0.01), from 72±3 to 25±2 mEq/day in Case 2 (p<0.01) and from 55+2 to 22±2 mEq/day in Case 3 (p<0.01). Moreover, the average sodium and chloride excretions decreased significantly in Case 1 (Na: 120±13 vs. (3) Half-saline diuresis studies before and after magnesium infusion (Table 1) In all three patients, plasma arginine vasopressin was less than the detection limit through half-saline infusion studies. Before magnesium infusion, free water clearance (CH2o) was depressed remarkably to approximately half of the normal value (4) in Cases 1 and 2, whereas the impairment in Case 3
was slight (Table 1) . Fractional distal chloride reabsorption (normal: >80%, ref.
3) was impaired in all three cases; 64, 62, 63% in Cases 1, 2, and 3, respectively (Table 1) . Free water clearance (CH2q) after 7<lay magnesium infusion did not improve at all. Neither did distal fractional chloride reabsorption improve at all after magnesium infusion in two patients. However, it was slightly improved in Case 3, although still muchlower than the normal value (Table 1) . Plasma and urinary osmolality and urinary volume did not change appreciably after magnesium infusion.
Discussion
The diagnosis offamilial Bartter' s syndrome was confirmed in the present three sibling patients, with hypokalemic alkalosis, high plasma renin activities, normal blood pressure, resistant to angiotensin II [Case 2, 3] and the hyperplasia of juxtaglomerular apparatus [Case 1]. Bartter's syndrome is sometimes genetically transmitted in an autosomal recessive manner. In few instances the defect in distal fractional chloride reabsorption was described for all affected siblings (15) . In our study, all affected siblings showed decreased distal fractional chloride reabsorption, which was originally proposed as the proximate cause of this syndrome by Gill and Bartter (3) . Hypomagnesemiahas also been found in the syndrome in some of the patients. It was marked in Cases 1 and 2, and mild in Case 3. Since magnesium divalent ion is predominantly reabsorbed in the thick ascending limb of the loop of Henle by active chloride reabsorption as the major driving force, namely the site where most of distal chloride reabsorption takes place, impairmentof renal magnesium conservation might also coexist in the syndrome (7, 8, 10) . Baehler et al (4) found that infusions of magnesium chloride (875 mg magnesium/day) restored the plasma magnesium level to normal, and corrected a defect in renal potassium wasting, remarkably improved plasma potassium, but failed to normalize PRAand PACin a sporadic case ofBartter's syndrome with hypomagnesemia. However, in familial Bartter's syndrome such studies have yet to be dpne. Moreover, since they used a chloride compoundto supplement magnesium,the changes in urinary chloride excretion were not assessed (4) . A large amountof chloride ion might also affect the reabsorption of sodium and potassium in the renal tubule. Therefore the correction of renal potassium wasting might not be solely due to magnesiumsupplementation.
Wehave clearly demonstrated that in all three siblings with familial Bartter's syndrome, infusion of magnesiumsulphate (400 mg magnesium/day) normalized plasma magnesium and induced decreases in urinary potassium, sodium and chloride excretions and subsequent elevation in plasma potassium. Since sulphate is one ofnon-reabsorbable anion in renal tubule, it may aggravate hypokalemia by distracting the proton in the lumen.
Therefore the correction of potassium is not due to the effect of sulphate. Magnesium supplementation decreased PRAand PAC in Cases 1 and 2. The decrease in PRAand PAC after magnesium infusion may be due to a correction ofhypovolemia mediated by improved sodium and chloride reabsorption. In Case 3, corrections of urinary loss of chloride and sodium by magnesium infusion were small, therefore PRAand PACwere not decreased appreciably. The smaller degree of correction in serum electrolytes maybe due to milder hypokalemia and hypomagnesemia of Case 3, before loading magnesium sulphate comparedto the other two cases. Apossible role for magnesiumas a modulator of the reninaldosterone system is suggested by results of magnesiumadministration in several cases of hypomagnesemia. Plasma aldosterone concentration has been reported to increase in response to magnesiumdeprivation ( 1 6) . Hyperaldosteronism induced by magnesium depletion might be functionally significant with respect to the pathogenesis of the concomitant renal potassium wasting. The improvementin renal handling of potassium in Cases 1 and 2 might be therefore the consequence of reduced levels of aldosterone. However,the unchangedPAC in Case 3 presumably reflected other mechanisms that improved renal potassium wasting. Cellular depletion of magnesium in the loop ofHenle maybe the major cause of the renal potassium wasting since the reabsorption of potassium in the loop of Henle is dependent upon reabsorption of sodium and the driving force for sodium reabsorption is generated by the activity of a magnesiumdependent enzyme, namely Na-K-ATPase localized in the basal lateral membrane.However,magnesiumrepletion failed to improve significantly fractional distal chloride reabsorption in all cases. Persistent abnormality in distal fractional chloride reabsorption after magnesium supplementsin all three cases maysupport the contention that impairment in salts reabsorption in the loop of Henle is the proximate cause of Bartter's syndrome. Correction of renal potassium, sodium and chloride reabsorption after magnesiumsupplement in this study, therefore, indicates that hypomagnesemiadecreases the compensatory increase in salts reabsorption in nephronsites other than the thick ascending limb of Henle. Distal delivery from the proximal tubule as estimated by CH2O+CC1 was persistently subnormal and unchanged in three siblings even after magnesium infusion ( Table 1 ). The enhanced reabsorption of sodium and chloride in the proximal tubule has been suggested when reabsorption of these ions is decreased in the ascending limb of the loop ofHenle (17) . Since magnesiuminfusion can curtail urinary potassium, sodium and chloride without a significant change in distal delivery, the site where magnesiumcorrection is exerted might not be the proximal tubules. Thus , hypomagnesemia (presumably, intracellular low magnesium) would inhibit the compensatory increases in salts reabsorption in the nephronsegmentsbeyondthe loop of Henle. In summary, the present data demonstrate that there are derangements of both sodium, potassium and chloride transport, and magnesium reabsorption in this familial Bartter's syndrome. Magnesiumdepletion mayundermine the compensatory increase in reabsorption of potassium, sodium and chloride in the nephron beyond the loop of Henle. Magnesium deficiency could be a deleterious factor causing electrolytes and volumeloss in familial Bartter's syndrome. Weconclude that magnesium depletion may be responsible, at least in part, for the deranged reabsorption of sodium, chloride and potassium in familial Bartter' s syndrome associated with hypomagnesemia.
